Shu-Chen Lyu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shu-Chen Lyu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Kari Christine Nadeau
Stanford University School of Medicine, Palo Alto, USA
3 shared publications - Rebecca Sharon Chinthrajah
Sean N. Parker Center for Allergy and Asthma Research Stanford University Stanford California USA
2 shared publications - Bianca Balbino
Argenx, Zwijnaarde, Ghent, Belgium
1 shared publication - Bryan Bunning
Stanford University
1 shared publication - Claudia Macaubas
Department of Pediatrics, Program in Immunology, Stanford University, Stanford, CA, United States
1 shared publication - Elizabeth D. Mellins
Department of Pediatrics, Stanford University, Stanford, CA, USA
1 shared publication
Latest Publications
- Open Access
- 4 May 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
A positive feedback loop reinforces the allergic immune response in human peanut allergy
Food allergies are a leading cause of anaphylaxis, and cellular mechanisms involving antigen presentation likely play key roles in their pathogenesis. However, little is known about the response of specific antigen-presenting cell (APC) subsets to food allergens in the setting of food allergies. Here, we show that in peanut-allergic humans, peanut allergen drives the differentiation of CD209+ monocyte-derived dendritic cells (DCs) and CD23+ (FcєRII) myeloid dendritic cells through the action of allergen-specific CD4+ T cells. CD209+ DCs act reciprocally on the same peanut-specific CD4+ T cell population to reinforce Th2 cytokine expression in a positive feedback loop, which may explain the persistence of established food allergy. In support of this novel model, we show clinically that the initiation of oral immunotherapy (OIT) in peanut-allergic patients is associated with a decrease in CD209+ DCs, suggesting that breaking the cycle of positive feedback is associated with therapeutic effect.
- 4 May 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
Open AccessA positive feedback loop reinforces the allergic immune response in human peanut allergy
Food allergies are a leading cause of anaphylaxis, and cellular mechanisms involving antigen presentation likely play key roles in their pathogenesis. However, little is known about the response of specific antigen-presenting cell (APC) subsets to food allergens in the setting of food allergies. Here, we show that in peanut-allergic humans, peanut allergen drives the differentiation of CD209+ monocyte-derived dendritic cells (DCs) and CD23+ (FcєRII) myeloid dendritic cells through the action of allergen-specific CD4+ T cells. CD209+ DCs act reciprocally on the same peanut-specific CD4+ T cell population to reinforce Th2 cytokine expression in a positive feedback loop, which may explain the persistence of established food allergy. In support of this novel model, we show clinically that the initiation of oral immunotherapy (OIT) in peanut-allergic patients is associated with a decrease in CD209+ DCs, suggesting that breaking the cycle of positive feedback is associated with therapeutic effect.
- Open Access
A highly sensitive bioluminescent method for measuring allergen‐specific IgE in microliter samples